No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
GNLX Genelux
- 2.280
- -0.090-3.80%
Close Jun 20 16:00 ET
- 2.500
- +0.220+9.65%
Post 18:45 ET
78.32MMarket Cap-2387P/E (TTM)
2.460High2.220Low196.32KVolume2.430Open2.370Pre Close455.81KTurnover0.72%Turnover RatioLossP/E (Static)34.35MShares35.15052wk High5.19P/B62.22MFloat Cap2.15052wk Low--Dividend TTM27.29MShs Float40.980Historical High--Div YieldTTM10.13%Amplitude2.150Historical Low2.321Avg Price1Lot Size
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Express News | Benchmark Reiterates Speculative Buy on Genelux, Maintains $25 Price Target
Unveiling 4 Analyst Insights On Genelux
Genelux (NASDAQ:GNLX) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.Summarizing their recent assessments, the table below illustrates
Genelux Is Maintained at Speculative Buy by Benchmark
Genelux Is Maintained at Speculative Buy by Benchmark
Genelux Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/31/2024 832.84% Benchmark $30 → $25 Maintains Speculative Buy 05/13/2024 1094.03% HC Wainwright & Co. →
Express News | Genelux Corp : Benchmark Cuts Target Price to $25 From $30
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersCue Health (NASDAQ:HLTH) stock moved upwards by 32.4% to $0.12 during Monday's pre-market session. The market value of their outstanding shares is at $19.8 million. SCWorx (NASDAQ:WORX) shares
Comments
Genelux Corporation: A Speculative Buy Worth Considering?
In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
In the volatile world of biotech investments, pinpointing potential high-reward stocks can be akin to finding a needle in a haystack. Yet, the recent analysis by Benchmark on Genelux Corporation (Ticker Symbol: GNLX) has caught the attention of many in the industry. With a reiterated speculative buy rating and a staggering price target of $30—nearly six times its current trading pri...
1
$Genelux(GNLX.US$ markets best kept secret right here
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg